MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
6
Page:
101-107
Author(s):
Ying Xia and Nikolaos G. Frangogiannis
Ryanodine Receptor - A Novel Therapeutic Target in Heart Disease
Journal:
Recent Patents on Cardiovascular Drug Discovery
Volume:
2
Page:
110-118
Author(s):
Rikuo Ochi and Sachin A. Gupte
Cardiac Fat as New Diagnostic Tool and Potential Therapeutic Target for Obesity Management and Treatment
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
1
Page:
162-165
Author(s):
Navneet Singh and Gianluca Iacobellis
Manoyl-Oxide Biotransformations with Filamentous Fungi
Journal:
Current Organic Chemistry
Volume:
11
Page:
679-692
Author(s):
Andres Garcia-Granados, Antonio Martinez, Andres Parra and Francisco Rivas
Cellular Therapy for Myocardial Repair
Journal:
Current Cardiology Reviews
Volume:
3
Page:
121-135
Author(s):
Julia Feygin, Abner M. Mhashilkar, Robert Deans and Jianyi Zhang
Tako-tsubo Cardiomyopathy: A Review of the Literature
Journal:
Current Cardiology Reviews
Volume:
3
Page:
137-142
Author(s):
Todd A. Dorfman, Raed Aqel, Marc Mayhew and Ami E. Iskandrian
Heat Shock Proteins - Two Sides of a Coin
Journal:
Current Cardiology Reviews
Volume:
3
Page:
143-148
Author(s):
Se-Chan Kim, Bum-Soo Kim, Li Lin and Anne A. Knowlton
Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Journal:
Current Hypertension Reviews
Volume:
3
Page:
137-142
Author(s):
Chanwit Roongsritong, Ashwani Kumar and Leigh Ann Jenkins
Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1295-1298
Author(s):
Agostino Molteni
Treatment of Experimental Myocarditis via Modulation of the Renin-Angiotensin System
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1299-1305
Author(s):
Melvin D. Daniels, Kenneth V. Hyland and David M. Engman